Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Myriad Genetics, |
RCV002309164 | SCV002602973 | likely pathogenic | Nephrotic syndrome, type 2 | 2021-12-03 | criteria provided, single submitter | clinical testing | NM_014625.2(NPHS2):c.635_636delAA(K212Sfs*21) is expected to be pathogenic in the context of nephrotic syndrome, NPHS2-related. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in NPHS2, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening. |